Nutra Products, Inc.
Home
Products
Clinicals
Press Releases
F.A.Q.
About NPI
Our Team
Distributors
Contact NPI

Garlic

  Line Press Releases

SFS Granted Patent on Alkalizing Compound

Nutrition Industry Executive
July/August 2011 Issue
www.niemagazine.com

Scientific Food Solutions' (SFS, Fairfield, CA), parent company Nutra Products Inc., has been granted U.S. Patent 7901717 B1 on an alkalizing compound, which SFS is using to make nutritional ingredients more palatable for consumers, thus improving compliance. The patent, dated March 8, 2011, is for an "Alkalizing Composition and Methods for Using the Same."

The patent covers several applications for products offered by SFS including Garli-Eze®, Comforteze®, FAST-C® and Aqua-Lyte™.

"There are a number of nutritional ingredients with important health benefits which many people don't tolerate well," said SFS President Gretchen Reece.
SFS Granted Patent on Alkalizing Compound
"This patented method will make those health benefits available to more consumers."

The abstract describes the patent as: "An alkalizing composition comprising calcium carbonate, potassium hydroxide, potassium bicarbonate and dicalcium phosphate. The alkalizing composition may further comprise any one or a combination of magnesium hydroxide, tricalcium phosphate, vitamin, a binder, sea minerals and water. The alkalizing compositions may be formulated as an antacid, a nutritional or dietary supplement, or a sports beverage. The alkalizing composition may be used in methods to buffer garlic. The buffered garlic compositions produced in accordance with the methods provides high allicin yield under acidic conditions. The alkalizing compositions may also be used in methods to enhance the flavor of fruits and vegetables."

For more information call (866)447-0875.

<< Back to Press Releases


Home | Products | Clinicals | Press Releases | F.A.Q. | About NPI | Our Team | Distributors | Contact Us
Copyright 2006 © All Rights Reserved - Nutra Products, Inc.

 

Site Design by: Melissa Dahle Web Design